Elektronische Erfassung des Longitudinalen Verlaufs Bipolarer Störungen
|
|
- Darcy Banks
- 6 years ago
- Views:
Transcription
1 Elektronische Erfassung des Longitudinalen Verlaufs Bipolarer Störungen Prof. Dr. Dr. Michael Bauer Charité Universitätsmedizin Berlin Charité Campus Mitte (CCM) Klinik für Psychiatrie und Psychotherapie
2 Bipolare Störungen Epidemiologische Basisdaten Lebenszeitprävalenz ca. 1-2% Spektrum 3-6% Prävalenz bei Frauen und Männern gleich 1/3 der Erkrankten unternimmt einen Suizidversuch, etwa 15-20% mit Erfolg Hohe Rezidivrate: > 90% Müller-Oerlinghausen, Berghöfer, Bauer (2002) Lancet
3 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 3
4 Bipolare Störung MANIE RAPID CYCLING NORMALE STIMMUNG DEPRESSION 12 Monate
5 W, 64, Bipolar II, Ultra Rapid Cycling Drug Legend #1 Lithobid (lithium carbonate) 300 mg #4 Remeron (mirtazapine) 30 mg #7 Premarin (conjugated estrogens) 1.25 mg #2 Effexor XR capsules (venlafaxine) 150 mg #5 Valium (diazepam) 10 mg #3 Effexor XR capsules (venlafaxine) 75 mg #6 Synthroid (levothyroxine) 25 mcg 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 5
6 Bipolar Disorder: Difficult to Study Bipolar disorder is > Episodic (manic, hypomanic, depressed, mixed, rapid cycling) > Recurrent and life-long illness > High variability within and between patients Major treatment goals: relapse and suicide prevention, interepisodic mood stability Longitudinal mood charting is essential methodology for diagnostic, treatment and research 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 6
7 Why Self-Charting? Only possibility to record daily Daily recording may capture observations that would be missed if data were only collected at clinical (doctors) visit Daily self-reported data provides doctor important information about a patients mood variation 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 7
8 Why Self-Charting? Study in bipolar disorder with weekly clinician ratings captured only 34.1% of days of depression and 14.1% of days of mania compared to daily patient selfreporting (Denicoff et al. 1997) 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 8
9 Why Self-Charting? Several studies in bipolar disorder: process of self-charting of illness parameters may enhance and compliance with prescribed medications (Denicoff et al. 2000, Post et al. 2003) Enhanced adherence to medication improves outcome 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 9
10 Benefits of Mood Charting Track pattern of disorder > Cycle (episode) length > Frequency > Episode type > Switching speed Track episode triggers (early warning signs of relapse) Track treatment response > New medications > Polypharmacy > Other treatments 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 10
11 Paper-Based Mood Charting NIMH Life Chart (R. Post) STEP-BD Mood Chart (G. Sachs) Chronosheet (P. Whybrow) Used for individual treatment, patient education and longitudinal studies 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 11
12 Traditional Longitudinal Studies Paper-based mood charting instruments Expensive High patient drop-out rate High missing value rate Large imbalances in number of observations 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 12
13 Traditional Data Quality Handwritten documents Data entry introduces errors Slow analysis Poor patient compliance Recall errors 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 13
14 Computers Commonplace Worldwide 47% increase in household personal computers since % of US households have 1 personal computers Microsoft Windows used on 90% of personal computers in US Microsoft Windows used on 85% of personal computers worldwide 60% of households in Australia, Denmark, Netherlands, Norway, Singapore, South Korea and Sweden have 1 personal computers as of Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 14
15 Automating Data Collection Error checks at time of data entry Data definition is standardized Preferred by many patients Used to monitor a variety of chronic illnesses 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 15
16 Technology Options: Overview Common technologies that have been used to automate patient data collection for a variety of medical conditions are: >PDA (Personal digital assistant) >IVR (Telephone/Interactice Voice Response) >Web-based software >Software on a home computer Each technology has strengths and weaknesses 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 16
17 Personal Digital Assistant (PDA) Strengths >Eliminates data entry errors >Devices are portable and re-usable by study sponsor Weaknesses >Most software is not validated >Not suitable for text entry >Devices can be hard to read >Devices can be lost or stolen >Data is not secure >High maintenance cost 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 17
18 Integrated Voice Response (IVR) Strengths >Very easy to use >Patients only need a touch-tone phone >No costs to patient Weaknesses >Simple yes/no or multiple choice questions only >High initial cost to sponsor 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 18
19 Web Based Software Strengths >Eliminates data entry costs >No patient hardware costs for sponsor Weaknesses >Patients must have access to a computer >On-line system security requires trained IT staff to monitor 24 by 7 >Custom software development is expensive 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 19
20 Software On Home Computer Strengths >Eliminates data entry costs >No patient hardware costs for sponsor >Low administrative support costs Weaknesses >Patients must have access to a computer >Security must be designed into the system >Custom software development is expensive 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 20
21 Technology Selection Evaluate technology alternatives for each unique project, patient population and clinical setting Use validated software or devices (FDA) Consider on-going administrative and support costs, and initial development costs 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 21
22 Successful Projects Focus on Process A well-defined process is required for a successful project regardless of which technology is used On-going commitment of project sponsors and management Process documentation for staff and patients Staff and patient training Clear assignment of responsibilities On-going security and privacy management 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 22
23 Development of ChronoRecord Software for Personal (Home) Computer University of California Los Angeles (UCLA), Neuropsychiatric Research Institute Michael Bauer, UCLA, Berlin Michael Bauer, UCLA, Berlin Peter C. Whybrow, UCLA, CA Laszlo Gyulai, University of Pennsylvania, Philadelphia Tasha Glenn, ChronoRecord Association, Inc., Fullerton, CA, USA
24 ChronoRecord Goals Reduce missing data Reduce administrative costs Eliminate data entry errors Standardize data Reduce patient drop-out rates Provide feedback to patients and clinicians Accelerate analysis 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 24
25 ChronoRecord Patient Data Daily >Mood > Sleep > Medications > Life events Weekly weight Menstrual cycle for females 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 25
26 Patient Software 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 26
27 Patient Mood Entry 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 27
28 Patient Sleep Entry 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 28
29 Patient Medication Entry 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 29
30 Patient Data Management 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 30
31 ChronoRecord Data Security All patient and administrative programs are password protected All data stored on patient s computer is encrypted All data returned by diskette or is encrypted 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 31
32 Immediate Analysis Drug Legend #1 Depakote (divalproex) 250 mg #4 Clonazepam 1.0 mg #2 Depakote (divalproex) 500 mg #5 Zyprexa (olanzapine) 2.5 mg #3 Celexa (citalopram) 20 mg #6 Zyprexa (olanzapine) 5 mg 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 32
33 ChronoRecord Data Processing Data transferred from multiple sites to a central location All transferred data is encrypted All patient demographic, diagnosis and test data are available All patient identifying demographic data removed Data extracted to SQL compliant database using ODBC Daily medication summary table created 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 33
34 ChronoRecord Validation Study 96 patients with bipolar I or II diagnosis (DSM-IV) 3 academic centers UCLA (M. Bauer), Univ. of Ottawa (P. Grof) and Univ. of Pennsylvania (L. Gyulai) Patients entered data for 3 months Patient mood self-rating compared with HAMD and YMRS on 4 days 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 34
35 Validation Study Patient Sample 80 (83%) patients completed study Average of days of data per patient 6.1% missing mood data (similar for sleep and medication) Missing mood data not related to mood or demographics (MCAR) 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 35
36 Validation Study Analysis: Depression Strong correlation between ChronoRecord self-rated mood and HAMD (-.683, p<.001, N=281) Both linear regression and linear mixed model have significant coefficients 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 36
37 Validation Analysis: Mania Strong correlation between ChronoRecord selfrated mood and YMRS (.719, p<.001, N=107) Both linear regression and linear mixed model have significant coefficients Regression Mixed Model Outpatient* Inpatient ChronoRecord 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 37
38 Mania Validation Study Results ChronoRecord mood self-ratings validated with HAMD Insufficient manic ratings by clinicians to validate with YMRS Results published in Bipolar Disorders 2004:6;67-74 On-going collection of inpatient data in Berlin to validate with YMRS 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 38
39 Ongoing Mania Validation Preliminary Results 13 inpatients with mania added to 80 in previous study. Patient self-rated mood compared with YMRS and MRS over several weeks. Correlation between ChronoRecord self-rated mood and YMRS increased to (.580, p<.001, N=304) Correlation between ChronoRecord and MRS (.821, p<.821, N=12) 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 39
40 Validation Study Conclusions Patients like using ChronoRecord Immediate feedback of mood charts helps clinicians and patients Feedback increases long-term study participation rates Automated system produces high quality data for analysis 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 40
41 W, 40, Bipolar I, Dysthymic, Depressive Episode Drug Legend #1 Depakote (divalproex) 250 mg #4 Zoloft (sertraline) 100 mg #7 Topamax (topiramate) 25 mg #2 Desyrel (trazodone) 150 mg #5 Synthroid (levothyroxine - T4) 75 mcg #3 Remeron (mirtazapine) 30 mg #6 Topamax (topiramate) 100 mg 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 41
42 W, 22, Bipolar II, Lithium Non- Response, Response to Lamotrigine Drug Legend #1 Lithium Carbonate 300 mg #4 Zoloft (sertraline) 100 mg #2 Lamictal (lamotrigine) 25 mg #5 Risperdal (risperidone) 1 mg #3 Welbutrin SR (bupropion) 100 mg 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 42
43 W, 43, Bipolar I, Response to Lithium and Thyroid Hormone (T4) Drug Legend #1 Lithium Carbonate capsules 300 mg #4 Levothroid (levothyroxine - T4) 100 mcg #2 Depakote (divalproex) 500 mg #5 Levothroid (levothyroxine - T4) 200 mcg #3 Paxil (paroxetine) 40 mg 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 43
44 ChronoRecord Association The non-profit ChronoRecord Association distributes software at minimal cost For details, see Patient software available in 7 languages: English (US, Canada and UK), Spanish, German, Polish, Portuguese, Italian and Dutch Global data collection; database > 350 patients 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 44
45 Sites Using ChronoRecord Canada Martin Alda, MD, Dalhousie University, Halifax Paul Grof, MD, University of Ottawa Germany Michael Bauer, MD, Charité University Medicine Berlin Tom Bschor, MD, Technische Universität Dresden Poland Janusz Rybakowski, MD, Karol Marcinkowski University of Medical Science, Poznan Aleksandra Suwalska, MD, Karol Marcinkowski University of Medical Science, Poznan US UK Natalie Rasgon, MD, Stanford University Peter C. Whybrow, MD, University of California, Los Angeles Rodrigo A. Muñoz, MD, University of California, San Diego Laszlo Gyulai, MD, University of Pennsylvania Anthony Cleare, MD, Institute of Psychiatry, London 30-Aug-06 Bauer et al, Using Technology To Improve Longitudinal Studies.. in Bipolar Disorder 45
September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by
September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by Best Practices in the Management of Bipolar Disorder Robert M. A. Hirschfeld, MD University of Texas Medical Branch Galveston, TX Peter
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationDecreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder
Eur Arch Psychiatry Clin Neurosci (2011) 261:341 347 DOI 10.1007/s00406-010-0187-x ORIGINAL PAPER Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationAnti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of.
30-3-2007 Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of. 30-3-2018 C. Psychiatric drugs: controlled trial demonstrated
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationMental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Mood Disorders By Mary B. Knutson, RN, MS, FCP A Definition of Mood Prolonged emotional state that influences the person s whole personality and life functioning Adaptive Functions
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationDepression: Assessment and Treatment For Older Adults
Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca
More informationMultistate Outcome Analysis of Treatment MOAT
Multistate Outcome Analysis of Treatment MOAT Charles L. Bowden, M.D. Presented with Fond Memories of an Outstanding Statistician and Investigative Scientist Andy Leon Design contributors to low generalizability
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationBIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY
More informationFamily Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University
APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationBipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry
Bipolar Disorder Demystified Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Underdiagnoses of Depression In Primary Care 2005 Study of 650 primary care patients on antidepressants
More informationTreatment strategies in major depression What to use when?
Treatment strategies in major depression What to use when? Michael Bauer, MD, PhD Professor and Chair of Psychiatry University Hospital Carl Gustav Carus Technische Universität Dresden Germany First-line
More informationRecognizing Depression and Restoring Mood and Well- Being in the Older Patient
Recognizing Depression and Restoring Mood and Well- Being in the Older Patient Andreea L. Seritan, MD UC Davis Mini Medical School February 22, 2014 Objectives Review late life depression symptoms Review
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationBipolar Disorder. National Institute of Mental Health. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health
Bipolar Disorder National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 1 Contents What is bipolar disorder?... 4 What are the symptoms of bipolar
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationApril 2016 Prepared By: Kimberly D. Griego, PharmD, CGP
April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP Bipolar disorder (BD), also referred to as manic-depression, presents with dramatic swings in a person s mood and energy level, which affects their
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationBipolar Disorder in Adults
Bipolar Disorder in Adults What is bipolar disorder? Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability
More informationSupplement: Tables and Figures
Supplement: Tables and Figures Supplement Table 1. Baseline Characteristics by Study and Efavirenz Assignment Supplement Table 2. Baseline Psychoactive Medications by Efavirenz Assignment* Supplement Table
More informationIt's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum
It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum Session 4022: American Psychiatric Nurses Association National Conference, Louisville, KY Andrew Penn, RN, MS, NP, CNS Psychiatric
More informationIlluminating the Black Box: Antidepressants, Youth and Suicide
Illuminating the Black Box: Antidepressants, Youth and Suicide David H. Rubin, M.D. Executive Director, MGH Psychiatry Academy Director, Postgraduate Medical Education Director, Child and Adolescent Psychiatry
More informationMay 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:
May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult
More informationThe Essential Guide to Lithium Treatment
The Essential Guide to Lithium Treatment Michael Bauer Michael Gitlin The Essential Guide to Lithium Treatment Michael Bauer Technische Universtät Dresden University Hospital Carl Gustav Carus Dresden
More informationToo Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities
Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2010 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationDiabetes and Depression. Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C
Diabetes and Depression Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C 2008 Learning Objectives State the risk factors for depression Identify the vulnerability
More informationTable 1: Price increases for Brand Name Drugs with Generic Equivalents
Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%
More informationThe Pharmacological Management of Bipolar Disorder: An Update
Psychobiology Research Group The Pharmacological Management of Bipolar Disorder: An Update R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon.
More informationLithium is recommended as a first-line prophylactic
Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features Anne Berghöfer, M.D.; Martin Alda, M.D.; Mazda Adli, M.D.; Christopher
More informationmed ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.
med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,
More informationCrisis Intervention Team (CIT) Training
Crisis Intervention Team (CIT) Training Student Guide Bipolar Disorder Created by: Nils Rosenbaum Matthew Tinney Lawrence Saavedra Bipolar Disorder What is bipolar disorder? Bipolar disorder is a brain
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationWhat s new in the treatment of bipolar disorder?
What s new in the treatment of bipolar disorder? Dr. David Cousins MRC Clinician Scientist Institute of Neuroscience Newcastle University NCMD 2017 What s new in the treatment of bipolar disorder? Dr.
More informationA systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Bipolar Disorders 2013: 15: 115 137 Review Article Ó 2013 John Wiley and Sons A/S Published by Blackwell Publishing Ltd. BIPOLAR DISORDERS A systematic review of the evidence on the treatment of rapid
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/38787 holds various files of this Leiden University dissertation. Author: Koenders, Manja Title: Tangled up in mood : predicting the disease course of bipolar
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationMixing and Matching: Layering Medications as Family Physicians
Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples
More information8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation
Managing Psychiatric Conditions in Primary Care Beyond the Basics Source: US National Library of Medicine, Images from the History of Medicine Luis Berrios, DNP, MHA, ANP, PMHNP Internal Medicine & Primary
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Bipolar Depression: Putting the End Goal
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationObjectives. Bipolar disorder. APNA 27th Annual Conference Session 3012: October 11, Goossens 1
Care Indicator, a Self Management E-tool for Early Signaling and Intervention in Bipolar Disorder Dimence, Centre for Bipolar Disorders, Deventer, the Netherlands 1 Saxion University of Applied Sciences,
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationLithium in bipolar disorders.
Lithium in bipolar disorders. S. Mehdi Samimi Ardestani M.D. Department of Psychiatry, Shahid Beheshti University of Medical Science, Behavioral science research center Iranian psychiatric association,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 05 May 2010 LAMICTAL 2 mg, dispersible / chewable tablet B/30 (CIP: 354 581-7) LAMICTAL 5 mg, dispersible / chewable
More informationPsychiatric Consultant Role in Collaborative Care Sept 12, 2013
New York State Collaborative Care Initiative Psychiatric Consultant Role in Collaborative Care Sept 12, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationMedication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015
Medication Management Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015 1 Medication Management Objectives: 1. Principles of psycho-pharmacology
More informationHow To Treat Resistant Bipolar Patients
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/how-to-treat-resistant-bipolar-patients/3560/
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only
ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET
More informationKelly Godecke, MD Department of Psychiatry University of Utah
Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar
More informationTreating Chronic Illness in the PCMH Handout - Depression. A. Guidelines. 1. Control of Symptoms:
Treating Chronic Illness in the PCMH Handout - Depression A. Guidelines A quick note on diagnosis: Note: For a major depressive episode a person must have experienced at least five of the nine symptoms
More informationLAGUNA BEHAVIORAL Crown Valley Parkway, Suite 140 Phone: (949) Laguna Niguel, CA Fax: (949)
NEW PATIENT INFORMATION - ADULTS CLIENT INFORMATION Patient s Name: Today s Date: Other Names: Date of Birth: Age: Address: Street Apartment City State ZIP E-mail Address: May we contact you via e-mail
More informationGuidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationComprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula
Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder
More informationNIH Public Access Author Manuscript J Dual Diagn. Author manuscript; available in PMC 2013 May 01.
NIH Public Access Author Manuscript Published in final edited form as: J Dual Diagn. 2012 January 1; 8(4): 326 332. doi:10.1080/15504263.2012.723318. A Pilot Study of Mood Ratings Captured by Mobile Phone
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationThe Context: Why is this so important to treat?
Depression for PG1s Ian A. Cook, M.D. UCLA Department of Psychiatry Laboratory of Brain, Behavior, and Pharmacology Semel Institute for Neuroscience & Human Behavior DepressionLA.com PsychiatryGuidelines.com
More informationChallenges in identifying and treating bipolar depression: a guide
Challenges in identifying and treating bipolar depression: a guide Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Overview Challenges in
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationPsychopharmacology: An Overview
Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial
More informationJohn E. Kraus, M.D., Ph.D.
John E. Kraus, M.D., Ph.D. Chief, Adult Psychiatry, Dorothea Dix Hospital, Raleigh, NC Assistant Professor/Associate Director of Residency Training, Dept. of Psychiatry, UNC Hospitals, Chapel Hill, NC
More informationWELLBUTRIN COMBINATIONS MONITORING PAXIL BLOOD PRESSURE BAD
WELLBUTRIN COMBINATIONS MONITORING PAXIL BLOOD PRESSURE BAD Wellbutrin Combinations Monitoring Paxil Blood Pressure Bad To add lexapro wellbutrin why Mixed with wellbutrin suboxone And wellbutrin depression
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More information